The number of medical cannabis prescriptions approved by the Therapeutic Goods Administration (TGA) in March has surged again, falling just shy of 10,000 and up almost 2,000 (23.5%) on the February figure.
The TGA approved 9,959 prescriptions in March, up from February’s then all-time high of 8,057.
The TGA has now approved more than 100,000 SAS Category B applications for unapproved medicinal cannabis products as of March 31, 2021.
But as with February’s unusually high spike, it is believed the increase could be partially down to Australia’s flower shortage, as doctors sought reapprovals for the same patient after their first choice product could not be sourced.
The number of Authorised Prescribers has yet to be updated on the TGA website, with the figure remaining at 215 as of February 28, 2021.